Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2024

BUY
$2.13 - $3.85 $168,146 - $303,926
78,942 New
78,942 $182,000
Q1 2022

Jun 20, 2023

BUY
$2.13 - $3.85 $168,146 - $303,926
78,942 New
78,942 $182 Million
Q4 2021

May 17, 2024

BUY
$3.39 - $6.76 $91,980 - $183,419
27,133 Added 49.25%
82,227 $309,000
Q4 2021

Jun 21, 2023

BUY
$3.39 - $6.76 $278,749 - $555,854
82,227 New
82,227 $309 Million
Q3 2021

May 17, 2024

SELL
$2.1 - $5.19 $63,399 - $156,686
-30,190 Reduced 35.4%
55,094 $178,000
Q3 2021

Jun 21, 2023

BUY
$2.1 - $5.19 $115,697 - $285,937
55,094 New
55,094 $179 Million
Q2 2021

May 17, 2024

BUY
$4.68 - $7.39 $91,348 - $144,245
19,519 Added 29.68%
85,284 $399,000
Q1 2021

May 17, 2024

BUY
$6.81 - $10.55 $447,859 - $693,820
65,765 New
65,765 $487,000
Q1 2021

Jun 26, 2023

BUY
$6.81 - $10.55 $447,859 - $693,820
65,765 New
65,765 $487 Million
Q4 2020

May 24, 2024

BUY
$3.33 - $7.18 $24,632 - $53,110
7,397 Added 10.63%
77,007 $552,000
Q4 2020

Jun 22, 2023

BUY
$3.33 - $7.18 $256,433 - $552,910
77,007 New
77,007 $553 Million
Q3 2020

May 24, 2024

SELL
$2.74 - $3.62 $74,541 - $98,482
-27,205 Reduced 28.1%
69,610 $230 Million
Q3 2020

Jun 26, 2023

BUY
$2.74 - $3.62 $190,731 - $251,988
69,610 New
69,610 $230 Million
Q2 2020

May 24, 2024

BUY
$3.07 - $4.68 $297,222 - $453,094
96,815 New
96,815 $332 Million
Q2 2020

Jun 26, 2023

BUY
$3.07 - $4.68 $297,222 - $453,094
96,815 New
96,815 $332 Million
Q1 2020

Jul 12, 2023

BUY
$2.28 - $6.6 $220,738 - $638,979
96,815 New
96,815 $358 Million
Q4 2019

Jul 12, 2023

BUY
$3.34 - $5.51 $323,362 - $533,450
96,815 New
96,815 $454 Million
Q3 2019

Jul 12, 2023

BUY
$2.23 - $4.61 $215,897 - $446,317
96,815 New
96,815 $311 Million
Q2 2019

Jul 12, 2023

BUY
$3.59 - $8.37 $347,565 - $810,341
96,815 New
96,815 $399 Million
Q1 2019

Jul 13, 2023

BUY
$7.71 - $11.24 $746,443 - $1.09 Million
96,815 New
96,815 $777 Million
Q4 2018

Jul 13, 2023

BUY
$7.3 - $18.3 $706,749 - $1.77 Million
96,815 New
96,815 $707 Million
Q3 2018

Jul 13, 2023

BUY
$9.77 - $17.15 $945,882 - $1.66 Million
96,815 New
96,815 $1.63 Billion

About Endo International plc


  • Ticker ENDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 235,143,008
  • Market Cap $68.8M
  • Description
  • Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocio...
More about ENDP
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.